Dan Călugăru1, Mihai Călugăru. Show Affiliations » 1. Department of Ophthalmology, University "Gr. T. Popa," Iaşi, Romania.
Abstract
Entities: Disease
Mesh： See more » AgedAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal, Humanized/therapeutic useBevacizumabGlaucoma, Neovascular/prevention & controlHumansInjections, IntravenousIntraocular PressureMaleMiddle AgedProspective StudiesRetinal Vein Occlusion/drug therapyVascular Endothelial Growth Factor A/antagonists & inhibitorsVisual Acuity/physiology
Substances： See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedVEGFA protein, humanVascular Endothelial Growth Factor ABevacizumab
Year: 2013 PMID： 23823507 DOI： 10.1016/j.ophtha.2013.01.064
Source DB: PubMed Journal: Ophthalmology ISSN： 0161-6420 Impact factor: 12.079